Introduction {#Sec1}
============

In mammals, the renin-angiotensin system (RAS) is one of the key factors in the regulation of blood pressure, electrolyte balance and cardiac function. Renin catalyzes the conversion of the 14 amino acid propeptide angiotensinogen into angiotensin I (AngI), which in turn is cleaved by the angiotensin-converting enzyme (ACE) to produce angiotensin II (AngII)^[@CR1]^. AngII participates in a series of intracellular signaling cascades via activation of its receptors AT~1~ and AT~2~, which belong to the superfamily of seven-transmembrane domain G-protein coupled receptors (GPCR)^[@CR2]^.

Most of the classical actions associated with AngII are dependent on the activation of the AT~1~ receptor (AT~1~R)^[@CR3]^. Binding of AngII results in rapid phosphorylation of the receptor that facilitates β-arrestin recruitment induced desensitization and internalization of AT~1~R^[@CR4],\ [@CR5]^. Thus, activated AT~1~R is phosphorylated by GPCR kinases (GRKs) and subsequently β-arrestin is recruited to the receptor. This receptor/β-arrestin interaction leads to receptor desensitization, ending the G protein-dependent signaling by interfering with the coupling between the G protein and its receptor. Furthermore, β-arrestin can also bind to components of the clathrin coat, causing internalization of activated receptors and target to degradation pathways or recycled back to the cell surface^[@CR6],\ [@CR7]^.

Several recent studies have demonstrated the existence of macromolecular complexes involving GPCRs and various ion channels. For example, the dopamine D1 receptor regulates the NMDA receptor through a direct interaction^[@CR6]^. AT~1~R co-immunoprecipitates with the non-selective cation channel TRPV4^[@CR7]^ and with K~V~4.3, which is responsible for the fast transient outward current (I~to~) in cardiac myocytes^[@CR8]^. Likewise, it has been shown that voltage dependent calcium channels (VDCC) interact with various GPCRs. For instance, N-type Ca^2+^ channels interact with ORL1^[@CR9]^, GABAb^[@CR10]^ and the dopamine D1^[@CR11]^ and D2^[@CR12]^ receptors. Interestingly, most of these interactions lead to endocytosis of the channel following activation of the respective receptor^[@CR8],\ [@CR9],\ [@CR11],\ [@CR13]^.

In general, VDCCs are protein complexes involving at least three subunits: a Ca~V~α~1~ subunit that forms the channel pore, and Ca~V~α~2~δ and Ca~V~β accessory subunits, responsible for trafficking of the channel complex^[@CR14]^ to the plasma membrane. In cardiomyocytes, LTCC clusters, with specific subcellular localization, have been associated with specific functions. Thus, LTCC localized at the T-tubules are mainly responsible for excitation-contraction coupling by its association with ryanodine receptor 2 (RyR2) channels, while LTCC localized at the sarcolemma are implicated in signaling to the nucleus and regulation of gene transcription^[@CR15]^.

Several studies have convincingly shown that AngII modulates L-type currents. However, this modulation appears to depend on the cell type and on the species studied. For example, AngII induces an increase of L-type currents in smooth muscle cells^[@CR16]^ by a PI3Kdependent mechanism^[@CR17],\ [@CR18]^, while in neurons^[@CR19],\ [@CR20]^ and in glomerular cells, a decrease in these currents has been observed via a Pertussis toxin sensitive G-protein pathway^[@CR21]^.

In cardiomyocytes, the effect on this current after AngII application has been shown to be dependent on the species and the patch-clamp configuration used. In hamster^[@CR22]^ and guinea pig^[@CR19]^ the L-type current is increased, while in rabbit^[@CR23]^ and cat^[@CR24]^ no change is observed in cells studied with conventional whole-cell (WC) recordings, in contrast, perforated patch experiments show a potentiation of the L-type current. Finally, in rat^[@CR25]^ and human^[@CR26]^ a decrease of the L-type current has been reported using the conventional WC configuration, while the use of perforated patch configuration in newborn rat cardiomyocytes shows that the degree of L-type current inhibition depend on the speed of inactivation of L-type currents^[@CR27]^. This evidence together with a growing number of reports, establishes a clear link between VDCC and GPCRs, suggesting the existence of a functional association between L-type calcium channels and AT~1~R.

In this work, we demonstrate that AngII stimulation of AT~1~R causes β-arrestin~1~ (but not β-arrestin~2~) recruitment of the L-type calcium channel complex. From a functional stand point, AT~1~R activation induces internalization of the T-tubule Ca~V~1.2 population after prolonged exposure to AngII, leading to \~60% reduction of endogenous L-type calcium currents, diminished calcium transient amplitude, and reduced action potential duration.

Methods {#Sec2}
=======

Constructs {#Sec3}
----------

cDNA encoding the angiotensin receptor 1, AT~1~R (NM_000685), was obtained from the University of Missouri-Rolla cDNA resource center. cDNAs for calcium channel subunits (GenBank™ accession numbers: X15539 (Ca~V~1.2) and AF286488 (Ca~V~α~2~δ~1~) were kindly provided by Dr. T. Snutch. Ca~V~β~2b~ channel subunit (AF423193) was cloned as described in Moreno *et al*.^[@CR28]^. The HA epitope inserted into the extracellular S5-H5 loop of domain II of Ca~V~1.2 for the HA-tagged Ca~V~1.2 construct is described previously^[@CR29]^. Ca~V~1.2-YFP and Ca~V~β~1b~-YFP were PCR amplified and subcloned into the N1-YFP vector (Clontech) between the NheI and BamHI or EcoRI and BamHI restriction sites respectively. β-arrestin-Rluc constructs were kindly provided by Dr. R. Ramachandran and AT~1~R-YFP construct was kindly provided by Dr. LM Luttrell.

AD-293 culture and transfection {#Sec4}
-------------------------------

Tissue culture of AD-293 cells (Agilent) was performed as recommended by the distributor. Transfection solutions for individual culture dishes (35 mm diameter) contained a mixture of cDNA expression vectors (1 μg for each L-type calcium channel subunits (Ca~V~α, Ca~V~β and Ca~V~α~2~δ subunits), 1 μg of AT~1~R and 100 ng of β-arrestin-RLuc) and were transfected into cells by the calcium phosphate method^[@CR27]^. Experiments were conducted at room temperature 2--3 days after transfection.

Isolation of cardiomyocytes {#Sec5}
---------------------------

Rats were bred in the Animal Breeding Facility from the Facultad de Medicina, Universidad de Chile (Santiago, Chile). All studies were done in accordance and with the approval of the Universidad de Chile Institutional Bioethical Committee. Male Sprague Dawley rats (150--200 gr) were anaesthetized with ketamine plus xylazine and euthanized by isoflurane overdose before heart excision. Ventricular myocytes were isolated by enzymatic digestion in a Langendorff perfusion apparatus. Briefly, the hearts were removed, mounted on a Langendorff apparatus and perfused with modified Tyrode solution containing (mM): 133.5 NaCl, 1.2 NaH~2~PO~4~, 4 KCl, 1.8 CaCl~2~, 1.2 MgSO~4~, 10 HEPES and 5.5 glucose (pH 7.4 with NaOH) to wash out residual blood in the coronary vessels, Ca^2+^ was replaced with 5 mM EGTA after 3 min wash. Digestion was done by perfusion of the heart with modified Tyrode solution containing 25 µM Ca^2+^, 0.45 mg/ml collagenase type II (Worthington) and 0.12 mg/ml protease IV (Sigma-Aldrich) at 37 °C for 7 min, after which the Ca^2+^ concentration was increased to 50 µM for 7 min and further to 400 µM for 5 min. Subsequently, the heart was removed from the Langendorff apparatus and the dissociated cardiomyocytes were suspended in 400 µM Ca^2+^-Tyrode solution containing 1 mg/ml BSA, 30 mM taurine and 5 mM pyruvate at room temperature, and the Ca^2+^ concentration was gradually increased to 1.8 mM. Adult rat cardiomyocytes were cultured on laminin-coated coverslips (10 µg/ml) for 2 hr prior to AngII stimulation.

Bioluminescence resonance energy transfer (BRET) {#Sec6}
------------------------------------------------

AD-293 cells were co-transfected with Ca~V~1.2-YFP and β-arrestin-Rluc fusion proteins (+Ca~V~β and Ca~V~α~2~δ) or Ca~V~β-YFP and β-arrestin-Rluc fusion proteins (+Ca~V~1.2 and Ca~V~α~2~δ). After 48 hours, cells were seeded into a 96-well microplate and coelenterazine H was added 10 minutes before AngII. Ca~V~1.2 recruitment of β-arrestin was detected every 25 seconds as the ratio of the light intensity measured at 535 ± 20 over 475 ± 20 nm using a Tecan fluorometer. BRET signal of cells expressing YFP and Rluc was compared with cells overexpressing only Rluc as control. Every BRET experiment was performed at a controlled temperature of 23 °C.

Antibody feeding assays {#Sec7}
-----------------------

AD-293 cells over-expressing hemagglutinin-epitope (HA-epitope) tagged Ca~V~1.2 (+Ca~V~β and Ca~V~α~2~δ~1~) and AT~1~R were incubated with anti-HA antibody (Roche) for 30 min at 37 °C. Subsequently, cells were stimulated with AngII (1 µM), washed with Hank's solution and fixed with 4% paraformaldehyde. Surface-remaining Ca~V~1.2 channels were labeled with a secondary antibody (1:1000) conjugated to Alexa Fluor 488 (green, Invitrogen) in PBS. Then, cells were permeabilized with 0.5% triton in PBS (+1% BSA) and total Ca~V~1.2 channels were labeled with a secondary antibody (1:1000) conjugated to Alexa Fluor 594 (red, Invitrogen) in PBS. For image analysis, images were collected on an inverted microscope (Olympus IX-81, UPLFLN 40XO 40x/1.3 oil-immersion objective) and acquired using CellR software (Olympus). All image analyses were performed with ImageJ.

To analyze HA-epitope-tagged Ca~V~1.2 internalization, the green signal was converted to a binary image by setting the threshold function to the onset of the frequency of staining intensities histogram. With this procedure, any green pixel (independent of its original intensity) is set to maximal intensity. To obtain the percentage of internalized channels, the resultant binary image was subtracted from the red signal. This new red-signal image represents the number of internalized channels and the integrated intensities were normalized by dividing them with the integrated intensity of the red signal (that represents the total amount of channels, see Supplementary Figure [1](#MOESM1){ref-type="media"}).

Immunofluorescence {#Sec8}
------------------

Adult rat cardiomyocytes were seeded on laminin pretreated coverslips and then incubated with AngII (1 µM) in the presence or absence of Losartan (100 nM) (Sigma). Subsequently, cardiomyocytes were washed with PBS and fixed with 4% paraformaldehyde. Cardiomyocytes were then permeabilized with 0.02% Triton X-100 in blocking buffer (3% BSA, 5% goat serum in PBS) and incubated for 16 hours with primary antibodies (Anti-Ca~V~1.2, Alomone \#ACC-003, rabbit polyclonal, Anti- βarrestin~1/2~, Santa Cruz \#SC-53781, mouse monoclonal, Anti-αActinin, Abcam \#AB-9465, mouse monoclonal) before addition of fluorescently labeled secondary antibodies and visualization by confocal microscopy. Intracellular signal percentage was calculated by integrating the cardiomyocyte surface fluorescence (defined by hand for each image) and subtracting it from the total integrated fluorescence. This ensuing signal was then normalized to the total integrated fluorescence.

Colocalization analysis {#Sec9}
-----------------------

Intensity Correlation Analysis, performed as described previously^[@CR29]^, is based on the principle that when two proteins colocalize their staining intensities should vary synchronously^[@CR30]^. Briefly, the Product of the Differences from the Mean (PDM) of each pixel was calculated and the Intensity Correlation Quotient (ICQ) was defined as the ratio of the number of positive PDM pixels to the total pixel numbers. The ICQ values are distributed between −0.5 and +0.5 by subtracting 0.5 from this ratio and a dependent staining is considered when the ICQ value range between 0 \< ICQ ≤ + 0.5.

Calcium Imaging {#Sec10}
---------------

Plated cardiomyocytes were mounted in a perfusion chamber on the stage of an inverted microscope (Olympus IX-81, UPLFLN 40XO 40 x/1.3 oil-immersion objective). Fluorescence was collected using a CCD-based imaging system (Olympus DSU) running CellR software (Olympus). Cardiomyocytes were incubated with Fluo-4 (Molecular Probes, 1 µM) as described in ref. [@CR28] and thoroughly washed with external solution (mM): 100 NaCl, 5 KCl, 2 CaCl~2~, 1 MgCl~2~, 90 sorbitol, 5 glucose and 10 HEPES (pH 7.4 adjusted with Tris-Base). Fluo-4 loaded cardiomyocytes were excited at 480 nm and the fluorescence emission at 510 nm was collected and recorded at 12 Hz. For each experiment, signals were recorded and the background intensity subtracted using equivalent regions of interest (ROI) outside the cardiomyocytes. Fluo-4 results are expressed as normalized fluorescence (F/F~0~).

Electrophysiology and data analysis {#Sec11}
-----------------------------------

Ca^2+^ currents were recorded by conventional whole-cell patch clamp^[@CR31]^. Borosilicate glass pipettes were pulled to 2--4 MΩ resistance and filled with internal solution containing (mM): 108 CsCl, 4 MgCl~2~, 2 CaCl~2~, 10 EGTA 10 HEPES, 5 MgATP and 0.6 LiGTP (pH 7.2 adjusted with CsOH). The bath solution contained (mM): 5 CaCl~2~, 1 MgCl~2~, 10 HEPES, 20 TEA-Cl, 10 glucose and 100 NMDG-Cl (pH 7.4 adjusted with Tris). Data were acquired at room temperature using an Axopatch 200B amplifier and pClamp 10 software (Axon Instruments), low pass-filtered at 5 kHz, and digitized at 10 kHz. Series resistance was compensated to 85%. Data analysis, currents fitting and offline leak subtraction were performed in Clampfit 10 (Axon Instruments), and SigmaPlot 11 (Jandel Scientific). Current-voltage (IV) plots were fitted using a modified Boltzmann equation:$$\documentclass[12pt]{minimal}
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For action potential (AP) recordings, current-clamp mode was used and APs were elicited by 1 min trains of short (2 ms) depolarizing current injections at a frequency of 1 Hz, the average of the last 30 APs was used for analysis. Intracellular solution for these recordings was (mM): 120 KCl, 1.5 MgCl~2~, 0.01 CaCl~2~, 0.5 EGTA, 10 HEPES, 5 MgATP and 0.6 LiGTP (pH 7.2 adjusted with KOH). Extracellular solution was: 140 NaCl, 4 KCl, 1 MgCl~2~, 2 CaCl~2~, 10 Glucose and 10 HEPES (pH 7.4 adjusted with NaOH).

Measurement of myocyte shortening {#Sec12}
---------------------------------

Contractile properties of isolated ventricular myocytes were determined by measuring the fractional shortening of single cell cardiomyocyte at room temperature and superfused with external solution (mM): 100 NaCl, 5 KCl, 2 CaCl~2~, 1 MgCl~2~, 90 sorbitol, 5 glucose and 10 HEPES (pH 7.4 adjusted with Tris-Base). Myocytes were field-stimulated with 2 ms pulses at 1 Hz. Cardiomyocyte shortening and relengthening was measured on the stage of an inverted microscope (Olympus IX-81, UPLFLN 40XO 40 x/1.3 oil-immersion objective) using a CCD-based imaging system in which the myocyte motion was collected and recorded at 12 Hz and analyzed with ImageJ.

Statistics {#Sec13}
----------

Data are presented as mean ± sem (n). Statistical analysis of the data was performed with SigmaPlot 11 (Jandel Scientific) using unpaired Student's *t*-test, and was considered significant at *P* \< 0.05. One-way ANOVA test was performed for samples exposed to multiple treatments and was considered significant at *P* \< 0.05.

Results {#Sec14}
=======

In live cells, β-arrestin recruitment to activated AT~1~R can be measured by the bioluminescence energy transfer (BRET) assay^[@CR32]^. AngII stimulated AD-293 cells overexpressing β-arrestin~1~/Rluc or β-arrestin~2~/Rluc together with AT~1~R/YFP display an increased BRET signal within the first minutes of stimulation (Fig. [1A](#Fig1){ref-type="fig"}). Notably, overexpression of L-type calcium channels (Ca~V~1.2, Ca~V~β and Ca~V~α~2~δ) in the same cells did not change the BRET signal (Fig. [1B](#Fig1){ref-type="fig"}). Given the fact that BRET can only occur between particles located within \~100 Å from each other, this approach enables the study of the AngII-mediated interaction between β-arrestin and Ca~V~1.2 channels in live cells. As shown in Supplementary Figure [2](#MOESM1){ref-type="media"}, a significant increase in BRET signal is observed upon AngII treatment only in those AD-293 cells expressing β-arrestin~1~/Rluc, AT~1~R and a YFP-tagged L-type calcium channel (Ca~V~1.2/YFP, Ca~V~β and Ca~V~α~2~δ), confirming the close proximity between Ca~V~1.2 complexes and activated AT~1~R. However, C-terminal fusion of YFP to the Ca~V~1.2 α subunit resulted in a relatively small BRET signal. Therefore, the experiment was modified to enhance the BRET signal by fusing YFP to the C-terminus of the Ca~V~β subunit (Fig. [1C and D](#Fig1){ref-type="fig"}), as Ca~V~β subunits has been shown to have physiological functions in the absence of Ca~V~α subunits^[@CR33]^. Besides the usual negative control (cells without the YFP construct), for these experiments we used cells expressing all the constructs, except Ca~V~1.2 (β-arrestin~1~/Rluc, AT~1~R, Ca~V~β/YFP and Ca~V~α~2~δ). Under this configuration, we detected significant BRET signal changes upon AngII stimulation in those cells expressing β-arrestin~1~/Rluc, AT~1~R and the YFP-tagged LTCC channel subunits (Ca~V~1.2, Ca~V~β/YFP and Ca~V~α~2~δ). Those cells lacking in Ca~V~1.2 (Fig. [1C and D](#Fig1){ref-type="fig"}) or AT~1~R (not shown) revealed no detectable changes in BRET signal. Interestingly, we only observed an increase in BRET signal upon β-arrestin~1~ (Fig. [1C](#Fig1){ref-type="fig"}) but not with β-arrestin~2~ overexpression (Fig. [1D](#Fig1){ref-type="fig"}), even though AT~1~R activation is able to recruit both β-arrestin isoforms (Fig. [1A and B](#Fig1){ref-type="fig"})^[@CR34]^. Importantly, under our experimental conditions AngII increased the net BRET signal in a concentration-dependent manner with an apparent EC~50~ of 130 ± 50 nM (Fig. [1E](#Fig1){ref-type="fig"}, n = 3).Figure 1BRET assay between AT~1~R or Ca~V~1.2 channel and β-arrestins upon AngII stimulation. Time course of BRET signal ratio from AD-293 cells transfected with β-arrestin~1~-RLuc (black circles) or β-arrestin~2~-RLuc (grey circles) plus AT~1~R-YFP alone **(A)** or AT~1~R-YFP plus the L-type calcium channel (Ca~V~1.2, Ca~V~β and Ca~V~α~2~δ) **(B)**. For negative controls (empty circles), AD-293 cells were transfected without the β-arrestins. Time course of BRET signal ratio from AD-293 cells transfected with β-arrestin~1~-RLuc (**C**) or β-arrestin~2~-RLuc (**D**) plus AT~1~R and a YFP-tagged L-type calcium channel (Ca~V~1.2, Ca~V~β/YFP and Ca~V~α~2~δ). For negative controls (empty circles), AD-293 cells were transfected without the Ca~V~1.2 subunit. Red lines correspond to the best fit to a single rectangular hyperbola. The BRET records are averages of at least five independent experiments (n = 5--8). (**E**) Concentration-response curve of AngII-induced increase in net BRET signal in AD-293 cells transfected with β-arrestin~1~-RLuc plus AT~1~R and a YFP-tagged L-type calcium channel (Ca~V~1.2, Ca~V~β/YFP and Ca~V~α~2~δ), the line correspond to the best fit to Hill equation, n = 3. Mean values ± sem are shown.

To confirm β-arrestin recruitment to the L-type channel macrocomplex in native cells, adult rat cardiomyocytes were isolated and stimulated with AngII. As expected for Ca~V~1.2 immunostaining, L-type calcium channels were observed in a regularly spaced array consistent with the arrangement pattern of T-tubules, as well as surface sarcolemmal staining (Fig. [2A](#Fig2){ref-type="fig"} and Supplementary Figure [3](#MOESM1){ref-type="media"}) which highlights different populations of LTCC in cardiomyocytes^[@CR35]^. Moreover, immunostaining with a β-arrestin~1/2~ antibody revealed that in the absence of agonist, these proteins are distributed along the T-tubules and the plasmalemma with a small cluster found into the nucleus (Fig. [2A](#Fig2){ref-type="fig"}). A higher amount of β-arrestin~1/2~ into the T-tubule network was readily observed upon addition of AngII (30 min, 1 µM, Fig. [2B](#Fig2){ref-type="fig"}). To estimate the degree of colocalization of both proteins at the plasma membrane we submitted our data to intensity correlation analysis^[@CR30]^, a methodology that assumes that if two proteins colocalize, their fluorescence intensities should vary synchronically above the mean fluorescence (see methods). Intensity correlation analysis revealed an increase in the mean Intensity Correlation Quotient (ICQ) values for Ca~V~1.2 and β-arrestin~1/2~ upon AngII stimulation (Control: 0.18 ± 0.05, n = 6; AngII: 0.29 ± 0.03, n = 8; p \< 0.01), which suggests that β-arrestin is mobilized to the site of L-type calcium channel and thus, showing enhanced colocalization in acutely isolated rat cardiomyocytes.Figure 2Ca~V~1.2 and β-arrestin~1/2~ immunolocalization in adult cardiomyocytes. Representative confocal images of Ca~V~1.2 (left) or β-arrestin (middle) immunofluorescences in cardiomyocytes control **(A)** or treated with AngII (1 µM) for 30 min **(B)**, the overlay of individual images is shown on the right panel. All fluorescence images were collected at the same gain setting of the microscope. The images are representatives of 6 independent experiments.

Binding of β-arrestin to AT~1~R results not only in the desensitization of the heteromeric G-protein response, but also in the recruitment of various components of the endocytic machinery which promotes internalization of the activated receptors from the cell surface^[@CR36]^. To explore if binding of β-arrestin resulted in Ca~V~1.2 internalization, we performed antibody feeding experiments (see methods) in AD-293 cells overexpressing an extracellularly tagged Ca~V~1.2 subunit (HA-Ca~V~1.2) and AT~1~R (Fig. [3](#Fig3){ref-type="fig"}). With this protocol, the channels that remained at the membrane were immunolabeled in no-permeabilized cells with a 488-green antibody, and the total of those channels initially localized at the cell surface (internalized plus those that remain at the membrane) immunolabeled with a 594-red antibody after permeabilized the cells with 0.5% triton, allowing for direct observation and relative quantification of internalized channels. Our results (Fig. [3](#Fig3){ref-type="fig"}) demonstrate a robust loss of Ca~V~1.2 signal at the plasma membrane confirming that activation of AT~1~R indeed promotes the internalization of HA-tagged Ca~V~1.2 channels.Figure 3Ca~V~1.2 internalization upon AngII exposure in overexpression system. **(A)** Confocal images of the distribution of HA-epitope-tagged Ca~V~1.2 constructs in AD-293 cells over-expressing Ca~V~1.2 (plus Ca~V~β and Ca~V~α~2~δ) and AT~1~R before (top) or after (bottom) treatment with 1 µM AngII (30 min). **(B)** Summary bar graph showing the percentage of channels localized at the plasma membrane, normalized to control condition. n = 6. \*p \< 0.01 compared with control cells. No-perm, cells before permeabilization, representing the Ca~V~1.2 channels that remain at the plasma membrane; Perm, cell permeabilized that represent the total of channels localized at the cell surface at the beginning of the experiment.

Likewise, immunostaining of Ca~V~1.2 in rat cardiomyocytes treated with AngII, at different time points, revealed a gradual removal of Ca~V~1.2 channel from the T-tubules (Supplementary Figure [3](#MOESM1){ref-type="media"} and Fig. [4](#Fig4){ref-type="fig"}). This was significant in rat cardiomyocytes treated with AngII (1 µM) for 1 hr (Fig. [4B and D](#Fig4){ref-type="fig"}) where predominantly surface sarcolemmal staining is observed. In contrast, rat cardiomyocytes simultaneously treated with a specific AT~1~R inhibitor (Losartan, 100 nM, 1 hr) and AngII were undistinguishable from unstimulated cells (99.8 ± 5.5%, n = 4, Fig. [4C](#Fig4){ref-type="fig"}). These results suggest that only the LTCC population localized at the T-tubules is susceptible to internalization after prolonged AT~1~R activation.Figure 4Ca~V~1.2 internalization in rat cardiomyocytes treated with AngII. Representative confocal images of Ca~V~1.2 immunofluorescence in rat cardiomyocytes, control **(A)** or treated with AngII (1 µM) for 1 hr without **(B)** or with **(C)** losartan (100 nM). All fluorescence images were collected at the same gain setting of the microscope, nucleus stained with DAPI. **(D)** Intracellular Ca~V~1.2 immunofluorescence staining intensity measurements normalized to control cardiomyocytes (n = 6--10 for each condition) from cardiomyocytes treated with AngII (1 µM) for different time points. \*p \< 0.01 with respect to control.

Control experiments involving α-actinin staining ruled out cardiomyocyte detubulation as an explanation of Ca~V~1.2 immunostaining loss after AngII treatment. In brief, an α-actinin antibody was used (Fig. [5](#Fig5){ref-type="fig"}) and the spacing between individual T-tubules was assessed by the power spectrum of each image after a fast Fourier transform of the signal. Thus, the power spike as a function of the spatial frequency describes the average distance between individual Z-discs in the cell (Control: 2.71 ± 0.06 μm; AngII: 2.56 ± 0.11 μm, n = 5; NS), demonstrating that α-actinin immunostaining was independent of AngII treatment in our experimental conditions (Fig. [5A and C](#Fig5){ref-type="fig"}). Likewise, the average distance between Ca~V~1.2 immunostaining bands obtained in control cardiomyocytes (2.77 ± 0.03 μm, n = 5; Fig. [5B](#Fig5){ref-type="fig"}), or in Ca~V~1.2 immunostaining treated with AngII and losartan (2.67 ± 0.10 μm, n = 4; Supplementary Figure [5](#MOESM1){ref-type="media"}) were identical, in contrast, the fast Fourier transformation of Ca~V~1.2 immunostaining from cardiomyocytes treated with AngII lacks in a peak (Fig. [5D](#Fig5){ref-type="fig"}), confirming that normal spacing of L-type channels is lost in these cardiomyocytes.Figure 5T-tubule integrity in rat cardiomyocytes treated with AngII. *Top:* representative confocal images of rat ventricular cells stained with an anti-α-actinin antibody (**A**,**C**) or an anti-Ca~V~1.2 antibody (**B**,**D**). *Middle*: Fluorescence intensity profiles, in arbitrary units, along the longitudinal axis of each cardiomyocytes. *Bottom*: graphs of the fast Fourier transformation of the fluorescence profile. **(A**,**B)** control cardiomyocytes; **(C**,**D)** cardiomyocytes treated with AngII (1 µM) for 1 hr.

To test if the AT~1~R activation has functional consequences on Ca~V~1.2, we explored the effect of AngII on endogenous L-type calcium currents in adult rat cardiomyocytes. As seen in Fig. [6A](#Fig6){ref-type="fig"}, AngII treatment (1 hr, 1 µM) induces a decrease of almost 60% of L-type calcium currents (I~max,\ Control~ 12.1 ± 1.8 pA/pF, n = 8; I~max,\ AngII~ 4.8 ± 0.4 pA/pF, n = 10; p \< 0.05) and a \~10 mv right-shift in the channel voltage dependence of activation as seen in representative I-V plots (Fig. [6B](#Fig6){ref-type="fig"}). L-type current kinetics were studied by fitting a single exponential to the rising phase (activation) or by setting up the residual current after 50 ms of pulse (R~50~) at different voltages (inactivation). We did not observe differences in the activation kinetics (Fig. [6C](#Fig6){ref-type="fig"}); however, cardiomyocytes treated with AngII displayed a faster inactivation kinetics as indicated by a decreased R~50~ at all voltage tested (Fig. [6D](#Fig6){ref-type="fig"}). In agreement with our BRET experiments (Fig. [1E](#Fig1){ref-type="fig"}), a concentration dependent response, with an apparent IC~50~ of \~300 nM was observed for L-type current reduction (Fig. [6E](#Fig6){ref-type="fig"}, n = 4--10).Figure 6Endogenous L-type currents from cardiomyocytes treated with AngII. **(A)** Representative whole-cell endogenous L-type Ca^2+^ current traces from cardiomyocytes control (upper traces) or treated with AngII (1 µM) for 1 hr (lower traces). Currents elicited by a voltage step protocol from --60 mV to + 50 mV in 10 mV increments, V~h~ = −80 mV. **(B)** Summary peak current *I/V* plots (mean ± sem) obtained from currents family as shown in **(A)**, black line represents the best fit to a Bolztman equation (see methods). **(C)** Voltage-dependence of the activation time constant (τ~act~, mean ± sem) of L-type Ca^2+^ currents **(D)** Graph showing the residual current after 50 ms of the depolarization pulse (R~50~, mean ± sem) versus command voltage of L-type Ca^2+^ currents. Faster inactivation rates result in lower R~50~ values. **(E)** Concentration-response curve of AngII-induced L-type calcium current reduction in rat cardiomyocytes, the line correspond to the best fit to Hill equation, mean values ± sem are shown. In every panel, control rat cardiomyocytes are represented with empty circles and rat cardiomyocytes treated with AngII with filled circles. (n = 4--10) \*p \< 0.01 with respect to control.

A reduction in L-type currents is predicted to have an impact on the magnitude and/or frequency of calcium transients and consequently, on cardiomyocyte contraction. To directly investigate this, we evaluated the effect of AngII on calcium mobilization and fractional shortening. Intracellular calcium was monitored in rat cardiomyocytes loaded with Fluo-4 and paced extracellularly with a 5 ms pulse at a frequency of 1 Hz. Figure [7](#Fig7){ref-type="fig"} illustrates representative intracellular calcium transients recorded in adult rat cardiomyocytes, in control, and treated condition (AngII 1 µM, 1 hr). As shown, calcium transients from rat cardiomyocytes exposed to AngII displayed a faster transient decay as compared to control (extracted from single exponential fits to the Ca^2+^ transient decay; Fig. [7D](#Fig7){ref-type="fig"}) suggesting that AngII also modifies SERCA activity^[@CR28]^. As expected from the reduced L-type calcium currents recorded, decreased calcium transient amplitudes are evident in rat cardiomyocytes treated with AngII (63.7 ± 1.3% reduction, Fig. [7C](#Fig7){ref-type="fig"}, p \< 0.05) together with slower time-to-peak. Moreover, fractional shortening assessment reveals that in rat cardiomyocytes stimulated at a frequency of 1 Hz and treated with AngII, the fractional shortening was reduced to 30.7 ± 3.7% (Fig. [7E](#Fig7){ref-type="fig"}), consistent with the observed reduction of the amplitude of calcium transients (Fig. [7C](#Fig7){ref-type="fig"}).Figure 7Calcium transients in cardiomyocytes treated with AngII. Representative normalized fluorescence (Fluo-4) recordings from cardiomyocytes control **(A)** or treated with AngII (1 µM) for 1 hr **(B)** and stimulated with a 5 ms external stimulus (1 Hz), individual points represent the signal for individual frames, acquire at 12 Hz. Below each fluorescence recording the respective line-scan images are shown. Bar graph (mean ± sem) of average maximal amplitude of electrically evoked Ca^2+^ transients **(C)** or time constant of Ca^2+^ decay **(D)** in cardiomyocytes control or treated with AngII (1 µM) for 1 hr. Data obtained after fitting individual calcium transients to a single exponential (n = 30--40, from 4 different cardiomyocytes preparations). \*p \< 0.01 with respect to control. **(E)** Bar graph (mean ± sem) of fractional shortening. For each bar graph, empty bars represents cardiomyocytes control and hatched bar cardiomyocytes treated with AngII (1 µM) for 1 hr. \*p \< 0.01 with respect to control.

Finally, action potentials are the result of the concerted activation of many ion channels, each of which defines distinct aspects of its shape. Careful inspection of APs confers an integrative manner to investigate putative changes in other voltage-dependent ion channels as a result of AngII prolonged stimulation. Action potential duration from ventricular cardiomyocytes was determined as the time where 20%, 50% or 90% of repolarization was attained (APD~20~, APD~50~ and APD~90~, respectively). Representative traces of superimposed APs from rat cardiomyocytes in control and after AngII treatment are displayed in Fig. [8A](#Fig8){ref-type="fig"}. Quantification of the repolarization phase shows significant differences at APD~90~ for AngII treated cardiomyocytes (Fig. [8C](#Fig8){ref-type="fig"}) suggesting that AngII treatment increases potassium currents in these cells. To examine other properties of the elicited action potentials, phase-plane plots were generated by graphing the voltage derivative in time (*d*V/*dt*) versus voltage as shown in Fig. [8B](#Fig8){ref-type="fig"}. AngII treatment does not produce significant alterations in the threshold potential, the depolarization slope or the maximal depolarization voltage. Furthermore, the resting membrane potential (RMP) remains unaltered after AngII treatment (Fig. [8D and E](#Fig8){ref-type="fig"}) which evidences lack of modification of voltage dependent sodium currents by the current experimental manipulations.Figure 8Action potentials from cardiomyocytes treated with AngII. **(A)** Representative action potentials waveforms from cardiomyocytes control (solid line) or treated with AngII (1 µM) for 1 hr (dashed line). Action potentials were elicited with a short (2 ms) depolarizing current injections (200--400 pA) at a frequency of 1 Hz. **(B)** Phase plot of the first derivative of membrane potential (d*V*/d*t*) against membrane potential (V~m~) for the action potentials shown in **(A)**. Control, empty symbols; AngII-treated, filled symbols. **(C)** Bar graphs (mean ± sem) of average action potentials duration (APD) estimated at 20%, 50% and 90% repolarization, APD~20~, APD~50~ and APD~90~, respectively. **(D)** Bar graph (mean ± sem) of maximal action potential amplitudes (Overshoot), threshold potentials and mean resting membrane potentials (RMP). **(E)** Bar graph (mean ± sem) of maximum rate of potentials change (*dV*/d*t*). For each bar graph, empty bars represents cardiomyocytes control and hatched bar cardiomyocytes treated with AngII (1 µM) for 1 hr. (n = 7--10) \*p \< 0.01 with respect to control.
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GPCR-ion channel macrocomplexes are thought to optimize transductional coupling by preventing the diffusion of signaling molecules and by modulating ion channel trafficking, either through regulation of channel surface expression or by mediating receptor-dependent internalization. The internalization process is slower than the activation of heteromeric G proteins activation (that usually occurs within seconds) and involves β-arrestin binding to phosphorylated receptors^[@CR37]^.

The acute effects of AngII on L-type currents in cardiomyocytes have been extensively studied and appear to be species specific^[@CR20],\ [@CR24]^, to depend on the experimental approach used^[@CR23]^ and/or on the different signaling molecules expressed^[@CR27],\ [@CR38],\ [@CR39]^. In contrast, the prolonged effects of AngII on LTCC have received less attention. Prolonged AngII stimulation has been shown to increase the amount L-type current in newborn but not in adult mice cardiomyocytes^[@CR40]^. In HL-1 myocytes, although there is a consensus that prolonged AngII-stimulation also induces an increase of L-type current, the reason for this is controversial, with a report showing a main role for β-arrestin~2~ ^[@CR40]^ and other showing a CREB-dependent *de novo* expression of Ca~V~α~1C~ ^[@CR41]^. Moreover, a recent study in canine cardiomyocytes suggested a dependence on the transmural muscular layer^[@CR42]^, suggesting the same species-specificity as for acute AngII stimulation.

Here, we show that in cardiomyocytes from adult rat AngII increases β-arrestin~1~ recruitment to L-type Ca^2+^ channel and reduces L-type Ca^2+^ current in a concentration-dependent manner, both processes with an EC~50~ and an IC~50~ in the order of \~100 nM, respectively (Figs [1E](#Fig1){ref-type="fig"} and [6E](#Fig6){ref-type="fig"}). This AngII concentration is orders of magnitude greater than the concentration of AngII found in plasma (in the order of pM). Nevertheless, it is in good agreement with recent literature showing that prolonged high-doses of AngII produce changes at the single cardiomyocyte level^[@CR42],\ [@CR43]^. This difference suggests that local RAS may play a fundamental role in this process since plasma levels of AngII are too low to efficiently modify LTCC levels located at the T-tubules. In fact, recent estimates of AngII levels in canine and rat T-tubules are in the order of 100 nM^[@CR42],\ [@CR44]^. Thus, the local RAS at the heart^[@CR45]^ could be important for electrically remodeling cardiomyocytes from different muscle layers, generating regional heterogeneities in action potential morphology and contractility^[@CR46]^. Similarly, our experiments show that prolonged stimulation with AngII leads the internalization of the L-type channel population located at the T-tubules membrane (Fig. [4](#Fig4){ref-type="fig"}).

It is generally agreed that the effects of AngII in the vasculature occur at low levels of this hormone which can be used to distinguish them from the effect of AngII in the cardiac system. This can be explained by differences in receptor affinity either by post translational modification or by the formation of tissue-specific macrocomplexes involving yet unidentified protein partners. However, more work is required to establish a clearer mechanistic understanding of this process.

It should be noted that despite differences in the magnitude of the BRET signals obtained with different constructs (Fig. [1](#Fig1){ref-type="fig"} and Supplementary Figure [2](#MOESM1){ref-type="media"}), the overall trend was consistent with a probable LTCC-β-arrestin~1~ interaction. These results are supported by immunostaining data obtained from adult rat cardiomyocytes (Fig. [2](#Fig2){ref-type="fig"}). We cannot ascertain the underlying reason for the difference in BRET signal amplitude, however some weight could be assigned to potentially different orientation of the energy transfer partners as the BRET signal depends on the orientation between donor and acceptor.

More interestingly, the BRET experiments reveal a preference for β-arrestin~1~ recruitment after AT~1~R activation as compared to β-arrestin~2~. When activated, the AT~1~R recruits both β-arrestin isoforms (Fig. [1](#Fig1){ref-type="fig"}), but ERK signaling pathway activation only occurs when β-arrestin~2~ but not β-arrestin~1~ is recruited^[@CR47]^. Thus, AT~1~R interaction with Ca~V~1.2 may represent a novel form of GPCR-dependent signaling regulation in which the presence of the macromolecular complex controls the specific recruitment of β-arrestin isoforms. Understandably, this hypothesis awaits experimental corroboration.

Functionally, chronic activation of AT~1~R leads to the internalization of Ca~V~1.2 in a heterologous expression system (Fig. [3](#Fig3){ref-type="fig"}) and in ventricular rat cardiomyocytes (Fig. [4](#Fig4){ref-type="fig"}). Interestingly, internalization of Ca~V~1.2 in ventricular cardiomyocytes appears to be restricted to the population of channels present at the T-tubules known to mediate the calcium-induced calcium release process and the plateau phase of action potentials. In turn, the plasmalemma channel counterpart known to be involved in gene transcription regulation, seems unchanged by chronic stimulation with AngII. This subcellular loci-specific difference could be explained by the selective localization of AT~1~R at the T-tubules^[@CR48]^ supporting the idea of the existence of an AT~1~R/Ca~V~1.2 macrocomplex in these cells.

As expected from the loss of Ca~V~1.2 signal at the T-tubule, L-type calcium currents are greatly reduced in cardiomyocytes treated with AngII (Fig. [6A](#Fig6){ref-type="fig"}). Interestingly, the remaining current display a 10 mV right-shift in the I/V curve and a faster inactivation kinetics (Fig. [6B and D](#Fig6){ref-type="fig"}), which could be a consequence either of post-translational modification of the L-type channels (as oxidation or phosphorylation due to AT~1~R activation) or, as the observed current depends mainly on the LTCC present at the plasmalemma, an indicative that the different population of LTCC between the T-tubules and the plasmalemma bears different auxiliary subunits that grant them with differential biophysical characteristics. Nevertheless, in accordance with the diminished calcium current, the calcium transient amplitudes (Fig. [7C](#Fig7){ref-type="fig"}) and cardiomyocyte shortening (Fig. [7E](#Fig7){ref-type="fig"}) are similarly decreased. Nonetheless, AngII treatment is not specific for L-type channels, as Ca^2+^-reuptake is faster in AngII-treated cardiomyocytes (Fig. [7D](#Fig7){ref-type="fig"}) likely implicating higher activity of SERCA, suggesting that AngII treatment could induce more profound changes in calcium handling than those related to mere modification of the L-type current.

Furthermore, action potential measurements (Fig. [8](#Fig8){ref-type="fig"}) allowed the monitoring of the coordinated behavior of various voltage-dependent ion channels. Despite a relatively low dependence of rat ventricular action potentials on L-type calcium currents, when compared with other species like rabbits or guinea pigs, the fact that the voltage threshold (Fig. [8D](#Fig8){ref-type="fig"}) and maximal *d*V/*dt* (Fig. [8E](#Fig8){ref-type="fig"}) were unaltered by AngII treatment clearly indicates that voltage-dependent Na^+^ channels were unaffected. Likewise, unchanged resting membrane potential in AngII-treated cardiomyocytes suggests that "leak" K^+^ channels are also unmodified. Both observations demonstrate that AngII-induced Ca~V~1.2 channel internalization does not imply an unselective effect on ion channels. In contrast, changes in APD~90~ suggest that in these tissues, a voltage-dependent K^+^-channel is activated by chronic AT~1~R stimulation which is yet to be identified.

Concerning the fate of the Ca~V~1.2 channels after prolonged AngII stimulation, those channels could be targeted either for degradation or for recycling after its internalization. In fact, a closer look of the plasmalemma-arising signal of rat cardiomyocytes treated with AngII (Figs [4](#Fig4){ref-type="fig"} and [5](#Fig5){ref-type="fig"} and Supplementary Figure [4](#MOESM1){ref-type="media"}) indicates a more continuous signal at the membrane edge when stained with a Ca~V~1.2 antibody, suggesting that at least part of the channels originally in the T-tubule network could be re-targeted to the plasmalemma. At the same time, as depicted from the signal loss of Ca~V~1.2 total intensity when AngII-treated cardiomyocytes are compared with control cardiomyocytes, part of the channels appear to be directed to degradation.

AT~1~R activation is well known to activate a series of intracellular signaling pathways^[@CR49]^, those channels remaining at the membrane are likely to undergo posttranslational modification, such as PKC or CaMKII-dependent phosphorylation. Interestingly, these signals are usually associated with activation of the L-type current^[@CR50],\ [@CR51]^, suggesting that after prolonged AngII stimulation the channels in the plasmalemma, usually associated with gene transcription, are more active emphasizing the role of the process described here in cardiac remodeling.

In summary, we demonstrate a novel signaling pathway involving AT~1~R activation and LTCC. This AngII-dependent intracellular signaling pathway selectively recruits β-arrestin~1~ after receptor activation, promoting internalization of Ca~V~1.2 channels. In adult rat cardiomyocytes, the AngII driven internalization of Ca~V~1.2 occurs almost exclusively at the T-tubules leading to a significant reduction of L-type calcium current and calcium transient amplitudes. Functionally, the results presented here provide insights into the mechanisms by which prolonged AngII exposure causes cardiac remodeling and could have major implications for understanding the molecular mechanisms controlling the electrical transmural gradient observed in the heart.
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